Feb 24, 2022 / 02:30PM GMT
Daniel R. Grosslight - Citigroup Inc., Research Division - Research Analyst
All right. Good morning, everyone, and welcome to the Citi Healthcare Services Conference on what is sure to be a very eventful day in the markets. We appreciate you tuning into the Teladoc presentation today. With us, we have Teladoc's CEO, Jason Gorevic; and Teladoc's CFO, Mala Murthy.
Welcome, Jason and Mala. We're very glad you could join us today and right after earnings, too. So we have a lot to chat about today. Just a little housekeeping. For those who want to ask questions, you can either ask it directly in the box on the top right of Citi Velocity or you can send e-mails to me directly at [email protected].
Questions and Answers:
Daniel R. Grosslight - Citigroup Inc., Research Division - Research AnalystAll right. Let's dig in, guys. I think I'd like to start out, really just given your recently reported earnings, on some questions that I fielded from investors around some confusion on the 2022 guide. So the full year guide was in line with consensus.